MRVI Sep 2024 7.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:40PM EDT. Market open.
| Previous close | 0.2900 |
| Open | 0.2900 |
| Bid | 0.0000 |
| Ask | 1.8000 |
| Strike | 7.50 |
| Expiry date | 2024-09-20 |
| Day's range | 0.2900 - 0.2900 |
| Contract range | N/A |
| Volume | |
| Open interest | 4 |
ZacksMaravai (MRVI) Advances in RNA Research With New Collaboration
Per Maravai LifeSciences (MRVI) management, this development by TriLink is set to advance nucleic acid-based therapies.
Business WireTriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
SAN DIEGO, May 13, 2024--TriLink BioTechnologies (TriLink®), a Maravai™ LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, is collaborating with the Johns Hopkins University to accelerate transformational research in RNA therapeutics and discovery. A new center within the Johns Hopkins Whiting School of Engineering will accelerate research and therapeutic development, leveraging TriLink’s leading RNA synthesis technology.
Simply Wall St.Maravai LifeSciences Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Maravai LifeSciences Holdings ( NASDAQ:MRVI ) First Quarter 2024 Results Key Financial Results Revenue: US$64.2m (down...
© 2024 Yahoo. All rights reserved.